Skip to main content
Paola Ghione, MD, Hematology, New York, NY, Memorial Sloan Kettering Cancer Center

PaolaGhioneMD

Hematology New York, NY

Hematologic Oncology

Assistant Attending

Overview of Dr. Ghione

Dr. Paola Ghione is a hematologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Torino Faculty of Medicine and has been in practice 9 years. She specializes in Diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, cutaneous lymphomas, hodgkin's lymphoma, T cell lymphoma.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2020
  • University of Torino Faculty of Medicine
    University of Torino Faculty of MedicineClass of 2011

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2020 - 2026

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution Experience
    Paola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma
    Paola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...
    Paola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Hospital Affiliations